ProCE Banner Activity

CE

Clinical and Guideline Updates on Systemic Therapies for Hepatocellular Carcinoma

Video

Watch this on-demand webcast of a live CCO webinar featuring expert discussion of how pharmacists can optimize care for patients receiving systemic therapies for hepatocellular carcinoma.

Pharmacists : 1.00 contact {hour} ({0.1} CEUs)

Released: June 16, 2022

Expiration: June 15, 2023

No longer available for credit.

Share

Faculty

Courtney C. Cavalieri

Courtney C. Cavalieri, PharmD, BCOP

Clinical Oncology Pharmacist
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah

Amber Draper

Amber Draper, PharmD, BCOP

Oncology Clinical Pharmacy Specialist
Clinical Coordinator,
Oncology
Emory Healthcare Winship Cancer Institute
Atlanta, Georgia

Provided by

This activity is provided in partnership with ProCE.

ProCE Banner

Supporters

This activity is supported by an educational grant from AstraZeneca.

AstraZeneca

Target Audience

The target audience for this activity pharmacists, including clinical, managed care, and specialty pharmacists, who care for patients with HCC as well as other stakeholders in hematology/oncology practice.

Program Learning Goal

The goal of this activity is to improve the knowledge, confidence, and competence of pharmacists in the management of patients with HCC.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate clinical data on the use of systemic treatment approaches for patients with early or intermediate-stage HCC
  • Design optimal, individualized care plans for patients with advanced HCC, both in the frontline and second-line treatment settings
  • Develop strategies to identify and mitigate unique adverse events associated with novel targeted therapies in patients with HCC
  • Identify patients who may benefit from ongoing clinical trials based on tumor characteristics, previous treatment, and patient characteristics and preferences

Disclosure

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Courtney C. Cavalieri, PharmD, BCOP

Clinical Oncology Pharmacist
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah

Courtney C. Cavalieri, PharmD, BCOP, has no relevant conflicts of interest to report.

Amber Draper, PharmD, BCOP

Oncology Clinical Pharmacy Specialist
Clinical Coordinator,
Oncology
Emory Healthcare Winship Cancer Institute
Atlanta, Georgia

Amber Draper, PharmD, BCOP, has no relevant conflicts of interest to report.

Staff Disclosure

Ryan P. Topping, PhD, has no relevant conflicts of interest to report.

Megan Cartwright, PhD, has no relevant conflicts of interest to report.

Timothy A. Quill, PhD, has no relevant conflicts of interest to report.

Gordon Kelley has no relevant conflicts of interest to report.

Jim Mortimer has no relevant conflicts of interest to report.

Kevin Obholz, PhD, has no relevant conflicts of interest to report.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from June 16, 2022, through June 15, 2023:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-0000-22-159-H01-P has been assigned to this home study, application-based activity. This activity is approved for 1.0 contact hours (0.1 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of an evaluation and post-test with a score of 65% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.